FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Aug 24, 2026
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on August 24, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 32bda89b-a59e-4c39-b1e2-190ead46a448
Inspection Facts
- Inspection number
- 1333532
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1198364 - 2023-02-08
- FDA Inspection 1092125 - 2019-05-13
- FDA Inspection 1002848 - 2016-11-14
- FDA Inspection 871580 - 2014-03-27
- FDA Inspection 740704 - 2011-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.